Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$8.06M Sell
1,579,828
-1,420,685
-47% -$8.67M 0.21% 129
2026
Q1
$18M Buy
3,000,513
+1,377,777
+85% +$9.11M 0.52% 43
2025
Q4
$9.46M Buy
1,622,736
+1,532,236
+1,693% +$8.53M 0.25% 113
2025
Q3
$499K Sell
90,500
-155,417
-63% -$844K 0.01% 382
2025
Q2
$964K Buy
+245,917
New +$1.01M 0.02% 341
2024
Q4
Sell
-300,432
Closed -$1.66M 455
2024
Q3
$2.07M Buy
300,432
+192,422
+178% +$1.14M 0.06% 227
2024
Q2
$800K Sell
108,010
-160,844
-60% -$1.13M 0.02% 322
2024
Q1
$1.96M Sell
268,854
-1,330,366
-83% -$11.4M 0.06% 222
2023
Q4
$9.92M Buy
1,599,220
+68,251
+4% +$306K 0.4% 79
2023
Q3
$6.25M Buy
+1,530,969
New +$5.97M 0.22% 120
2023
Q1
Sell
-167,802
Closed -$478K 358
2022
Q4
$478K Buy
167,802
+100,302
+149% +$170K 0.02% 275
2022
Q3
$80K Sell
67,500
-202,500
-75% -$193K ﹤0.01% 345
2022
Q2
$159K Buy
+270,000
New +$199K 0.01% 313
2020
Q1
Sell
-389,825
Closed -$2.93M 245
2019
Q4
$2.93M Buy
+389,825
New +$2.37M 0.21% 116

Other funds holding ARDX

J. Goldman & Co's ARDX Position: Q2 2026 in Review

J. Goldman & Co reduced its Ardelyx (ARDX) stake by 47% in Q2 2026, selling an estimated $8.67M and leaving 1,579,828 shares worth $8.06M. The position accounts for 0.21% of the portfolio, ranked #129.

J. Goldman & Co first reported a position in ARDX in Q4 2019 and has held it in 14 quarters since. The position peaked at $18M in Q1 2026. 249 funds tracked by Wall St. Rank hold ARDX as of Q2 2026.

  • J. Goldman & Co held 1,579,828 shares of Ardelyx worth $8.06M as of Q2 2026.
  • J. Goldman & Co sold 1,420,685 Ardelyx shares in Q2 2026, an estimated $8.67M.
  • Ardelyx made up 0.21% of J. Goldman & Co's portfolio in Q2 2026, its #129 holding.
  • J. Goldman & Co first reported a position in Ardelyx in Q4 2019 and has held it in 14 quarters since.
  • J. Goldman & Co's Ardelyx position peaked at $18M in Q1 2026.
  • 249 funds tracked by Wall St. Rank held Ardelyx as of Q2 2026.

Based on J. Goldman & Co's 13F filing for Q2 2026, filed 14 Aug 2026.